Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination Rupinder KaurShareen SinghJiki Robert Review 03 January 2022 Pages: 1 - 21
Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection Arbind KumarAashish SharmaSanjay Kumar Review 20 January 2022 Pages: 23 - 49
The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy Seyed Hossein AghamiriKhalil KomlakhMehran Ghaffari Review 12 January 2022 Pages: 51 - 60
Pathophysiological basis in the management of myasthenia gravis: a mini review Aiswarya BinuSarath S. KumarKrishnadas Madhu Review 21 January 2022 Pages: 61 - 71
Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents Run YangChangming TanMasoud Najafi Review 23 November 2021 Pages: 73 - 89
The effects of phytochemicals and herbal bio-active compounds on tumour necrosis factor-α in overweight and obese individuals: a clinical review Mohammad BagherniyaAtena MahdaviAmirhossein Sahebkar Review 08 January 2022 Pages: 91 - 110
Therapeutic benefits of flavonoids against neuroinflammation: a systematic review HamsalakshmiAnn Maria AlexSaravana Babu Chidambaram Review 15 January 2022 Pages: 111 - 136
Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases Fang HuaLingli ShiPeng Zhou Review 17 January 2022 Pages: 137 - 147
The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis Chia Siang Chia KowDinesh Sangarran RamachandramSyed Shahzad Hasan Short Communication 31 January 2022 Pages: 149 - 157
Rutin ameliorates malaria pathogenesis by modulating inflammatory mechanism: an in vitro and in vivo study Divya BhattSaurabh KumarDnyaneshwar Umrao Bawankule Original Article 21 January 2022 Pages: 159 - 171
Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm M. RatheeshSujatha SunilJayesh Tilwani Original Article 25 January 2022 Pages: 173 - 184
The analgesic effect and safety of preoperative versus postoperative administration of celecoxib in patients who underwent arthroscopic rotator cuff repair: a randomized, controlled study Junfeng YangShanfu WangJianwei Wang Original Article 30 January 2022 Pages: 185 - 191
Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study Meltem Alkan MelikogluEda Balkan Original Article 18 January 2022 Pages: 193 - 197
Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19 Parisa FeizollahiSomaieh matinMahdi Taghadosi Original Article 31 January 2022 Pages: 199 - 205
Comparison of the antibacterial activity of Australian Terminalia spp. extracts against Klebsiella pneumoniae: a potential treatment for ankylosing spondylitis Reece CourtneyIan Edwin Cock Original Article 06 January 2022 Pages: 207 - 223
Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats Mahendra Kumar TrivediSambhu MondalSnehasis Jana Original Article 08 January 2022 Pages: 225 - 232
Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-α production Paulo S. A. AugustoTamires C. MatsuiRenes R. Machado Original Article 30 November 2021 Pages: 233 - 241
The effects of metformin, pioglitazone, exenatide and exercise on fatty liver in obese diabetic rats: the role of IRS-1 and SOCS-3 molecules Kemal Ozan LuleErsin AkarsuIbrahim Yilmaz Original Article 24 January 2022 Pages: 243 - 250
Protective effect of methyl gallate on murine antigen-induced arthritis by inhibiting inflammatory process and bone erosion Luana Barbosa CorreaTatiana Almeida PáduaMaria G. Henriques Original Article 02 February 2022 Pages: 251 - 266
Alterations to microbial secretome by estrogen may contribute to sex bias in irritable bowel syndrome Lesha PretoriusAnton du Preez Van StadenCarine Smith Original Article 13 January 2022 Pages: 267 - 281
Topical phenytoin administration accelerates the healing of acetic acid-induced colitis in rats: evaluation of transforming growth factor-beta, platelet-derived growth factor, and vascular endothelial growth factor Nima FattahiAlina AbdolahiMohammad Raman Moloudi Original Article 13 January 2022 Pages: 283 - 290
In vitro and in vivo anti-inflammatory activity of Tetrastigma sulcatum leaf extract, pure compound and its derivatives Ravindra Jagannath WagholeAshwini Vivek MisarSachin Hanmant Jadhav Original Article 22 January 2022 Pages: 291 - 311
Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model Pariya KhodabakhshNilgoon KhoieHamed Shafaroodi Original Article 10 January 2022 Pages: 313 - 325
Curcumin and n-acetylcysteine cocrystal produced with supercritical solvent: characterization, solubility, and preclinical evaluation of antinociceptive and anti-inflammatory activities Alessandro R. PaulazziBianca O. AlvesLiz Girardi Müller Original Article 10 January 2022 Pages: 327 - 341
NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown? Mina T. Kelleni Commentary 25 November 2021 Pages: 343 - 348
Mechanism by which immune complexes are deposited in hosts tissue Isaac GinsburgMark Feldman Commentary 18 January 2022 Pages: 349 - 351
Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case–control study Mahsa MohajeriEhsan HorriatkhahReza Mohajery Correction 20 December 2021 Pages: 353 - 353